์ผํ๋ํธ๋ฅจ
**์ผํ๋ํธ๋ฅจ**์ ์์ํ์์ ์์ก ๋ณด์ถฉ, ์ ํด์ง ๊ท ํ ๋ฐ ์ฝ๋ฌผ ํฌ์์ ๋ก ์ฌ์ฉ๋๋ ๊ธฐ๋ณธ์ ์ธ ์ ์ง ์์ก์ ๋๋ค. ์ ์ฅ์ฑ, ๋ฑ์ฅ์ฑ(์๋ฆฌ์์ผ์) ๋ฐ ๊ณ ์ฅ์ฑ ์ ์ ๋ก ์ ๊ณต๋ฉ๋๋ค. > **์์ ํ:** ๊ณ ์ฅ์ฑ ์์ผ์๋ ์ผํฌ ์ ๊ฐ๋ ฅํ ํ์ฅ ์ฆ๋์ ๋ก ์ฌ์ฉ๋์ง๋ง, ํ์ฒญ ๋ํธ๋ฅจ ์์น์ ์ฃผ์ ๊น์ ๋ชจ๋ํฐ๋ง๊ณผ ์ดํ ๋ฑ์ฅ์ฑ ์์ก์ ํฌ์ฌ๊ฐ ํ์ํฉ๋๋ค.
์์ฉ ๊ธฐ์ : Isotonic and hypertonic formulations expand **plasma volume** and replace lost extracellular fluid. Hypotonic formulations provide free water and may promote oedema formation. When used for fluid replacement, NaCl (0.45% and 0.9%) will expand the plasma volume compartment. โ Compared with colloids, 2.5 to 3.0 times as much fluid must be given because the crystalloid is distributed to other fluid compartments.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Intravenous fluid replacement (including hypercalcaemia or hyperchloraemic alkalosis) ยท Dose not specified in monograph ยท IV ยท As directed ยท As needed ยท Treatment of choice for hypercalcaemia or hyperchloraemic alkalosis.
- Shock (rapid blood volume expansion) ยท Rate must not exceed 1 ml/kg/min ยท IV ยท As directed ยท Preoperative period or acute crisis ยท Use hypertonic saline. Must monitor serum sodium and follow with isotonic crystalloid.
- Corneal oedema ยท Dose not specified in monograph ยท Topical ยท As directed ยท As needed ยท Use 5% hypertonic ophthalmic ointment.
- Hypoadrenocorticism (long-term management) ยท Dose not specified in monograph ยท PO ยท As directed ยท Long-term ยท Enteric-coated products may have unpredictable efficacy in dogs.
- Intravenous fluid replacement ยท Dose not specified in monograph ยท IV ยท As directed ยท As needed ยท Treatment of choice for hypercalcaemia or hyperchloraemic alkalosis.
- Shock (rapid blood volume expansion) ยท Rate must not exceed 1 ml/kg/min ยท IV ยท As directed ยท Preoperative period or acute crisis ยท Use hypertonic saline. Must monitor serum sodium and follow with isotonic crystalloid.
- Corneal oedema ยท Dose not specified in monograph ยท Topical ยท As directed ยท As needed ยท Use 5% hypertonic ophthalmic ointment.
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Dehydrated animals (Hypertonic saline)
- Hypovolaemic animals (Hypotonic solutions)
์ด์๋ฐ์
- Peripheral oedema
- Hyperchloraemic acidosis (especially in compromised patients)
- Vagally mediated bradycardia (if hypertonic saline is administered >1 ml/kg/min)
- Stinging sensation (ophthalmic ointment)
๋ชจ๋ํฐ๋ง
- Serum sodium concentrations (especially before and after hypertonic saline)
- Acid-base status (monitor for acidosis)
- Heart rate (monitor for bradycardia during rapid hypertonic infusion)
- Hydration status and fluid balance
๊ณผ์ฉ๋
Excessive administration of normal saline can increase the risk of **hyperchloraemic acidosis** and **peripheral oedema**. Administration of hypertonic saline at fluid rates >1 ml/kg/min can cause a **vagally mediated bradycardia**.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.